UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF 
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November 2016

Commission File No.: 000-30668
 
NOVA MEASURING INSTRUMENTS LTD.
(Translation of registrant’s name into English)

Building 22 Weizmann Science Park, Rehovot
P.O.B 266
Israel
 (Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 

Form 20-F S Form 40-F £
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ 
 
Attached hereto and incorporated by way of reference herein is a press release issued by the Registrant and entitled: “Nova Reports Record Revenues for Third Quarter 2016”.

The GAAP financial statements tables included in the press release attached hereto are hereby incorporated by reference into the Registrant’s registration statements on Form S-8, filed with the Securities and Exchange Commission on the following dates: November 5, 2007 (File No. 333-147140); October 25, 2012 (File No. 333-184585) and March 6, 2015 (File No. 333-202550).
 
SIGNATURES 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

  
 
 
Date: November 2, 2016
 
NOVA MEASURING INSTRUMENTS LTD.
(Registrant)

By: /s/ Dror David
——————————————
Dror David
Chief Financial Officer



 
 
Company Contact:
Dror David, Chief Financial Officer
Nova Measuring Instruments Ltd.
Tel: +972-73-229-5760
E-mail: info@novameasuring.com
www.novameasuring.com
Investor Relations Contacts:
Hayden/ MS-IR LLC
Miri Segal
Tel: +917-607-8654
E-mail: msegal@ms-ir.com
Or
Brett Maas
Tel: +646-536-7331
E-mail: brett@haydenir.com
 
Company Press Release
 
Nova Reports Record Revenues for Third Quarter 2016

Expecting 4th Consecutive Record Revenue Year
 
Rehovot, Israel, November 2, 2016 - Nova Measuring Instruments (Nasdaq: NVMI), a leading innovator and a key provider of metrology solutions for advanced process control used in semiconductor manufacturing, today reported financial results for the third quarter of 2016, the period ended September 30, 2016.
 
Third Quarter 2016 Highlights:
 
·
Quarterly revenues grew 24% sequentially to record high of $44.1 million, up 9% year over year, exceeding the high end of the guidance
·
GAAP net loss of $4.8 million, or $0.18 per diluted share, inclusive of the non-recurring expense of $12.9 million related to royalty payment to the Israeli Office of the Chief Scientist
·
Non-GAAP net income of $9.4 million, or $0.34 per diluted share, up 100% sequentially and 49% year over year, exceeding the high end of the guidance
·
Continued penetration into the memory segment yielded two leading memory customers contributing more than 10% each to the quarterly products revenues

GAAP Results ($K)
 
     
Q3 2016
     
Q2 2016
     
Q3 2015
 
Revenues
 
$
44,060
   
$
35,575
   
$
40,446
 
Net Income (Loss)
 
$
(4,778
)
 
$
3,153
   
$
5,437
 
Earnings (Loss) per Diluted Share
 
$
(0.18
)
 
$
0.11
   
$
0.20
 
NON-GAAP Results ($K)
 
     
Q3 2016
     
Q2 2016
     
Q3 2015
 
Net Income
 
$
9,449
   
$
4,703
   
$
6,316
 
Earnings per Diluted Share
 
$
0.34
   
$
0.17
   
$
0.23
 
 
A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are part of this release. Non-GAAP results exclude amortization of acquired intangible assets, net adjustments of deferred tax assets, stock-based compensation expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off.
 

Management Comments
 
“It was a strong and well-executed quarter for Nova as we delivered significant growth in revenue and non-gaap profitability, exceeding our guidance,” commented Eitan Oppenhaim, President and Chief Executive Officer of Nova. “Strong demand across the entire breadth of our product offering in multiple segments drove record quarterly revenue, reinforcing our confidence in a strong second-half and positions us for another growth year. We are encouraged by our expanding market position, as we continue to solidify our Foundry presence while making significant inroads into the Memory space. This progress is evident by this quarter’s diversified customer mix that included four customers contributing more than 10% each to the quarterly products revenues, including two leading memory customers.”
 
Mr. Oppenhaim added, “During the quarter we continued to leverage our financial strength to maximize shareholder value, signing a royalty buyout agreement with the Israeli Office of the Chief Scientist, eliminating approximately $24 million in future obligations. The agreement, coupled with our efficient operational model, will enhance our financial flexibility and will allow us to invest in sustainable, profitable growth. As evident from this quarter’s results, our efforts are already bearing fruit, demonstrating that we are on a clear path toward achieving our long-term profitability target.”
 
2016 Fourth Quarter Financial Outlook
 
Management provided an outlook for the fourth quarter, the period ending December 31, 2016. Based on current estimates, management expects:
 
·
$42 million to $46 million in revenue
 
·
$0.23 to $0.29 in diluted GAAP EPS
 
·
$0.31 to $0.40 in diluted non-GAAP EPS
 
2016 Third Quarter Results
 
Total revenues for the third quarter of 2016 were $44.1 million, an increase of 24% compared to the second quarter of 2016, and an increase of 9% relative to the third quarter of 2015.
 
Gross margin for the third quarter of 2016 was 22%, and included $12.9 million of expense related to royalty buyout agreement with the Office of the Chief Scientist (currently known as the National Authority for Technological Innovation) and $1.9 million of expense related to inventory write-off. This is compared with gross margin of 53% in the second quarter of 2016 and compared with gross margin of 56% in the third quarter of 2015.
 
Operating expenses in the third quarter of 2016 were $16.6 million. This is compared with $15.4 million in the second quarter of 2016 and compared with $17.4 million in the third quarter of 2015.
 
On a GAAP basis, which included $12.9 million of expense related to royalty buyout agreement with the Office of the Chief Scientist and $1.9 million of expense related to inventory write-off, the company reported net loss of $4.8 million, or $0.18 loss per diluted share, in the third quarter of 2016. This is compared with net income of $3.2 million, or $0.11 per diluted share, in the second quarter of 2016. The company reported net income of $5.4 million, or $0.20 per diluted share, in the third quarter of 2015.
 

 
On a Non-GAAP basis, which excludes amortization of acquired intangible assets, net adjustments of deferred tax assets, stock-based compensation expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off, the company reported net income of $9.4 million, or $0.34 per diluted share, in the third quarter of 2016. This is compared with net income of $4.7 million, or $0.17 per diluted share, in the second quarter of 2016, and compared with net income of $6.3 million, or $0.23 per diluted share, in the third quarter of 2015.
 
Conference Call Information
 
Nova will host a conference call today, November 2, 2016, at 9 a.m. Eastern Time, to discuss the financial results and future outlook. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

U.S. Dial-in Number: 1-888-428-9480
ISRAEL Dial-in Number: 1 80 924 6042
INTERNATIONAL Dial-in Number: 1-719-457-2628
At:
9 a.m. Eastern Time
6 a.m. Pacific Time
3 p.m. Israeli Time

Please reference conference ID 2393527

The conference call will also be webcast live from a link on Nova's website at http://ir.novameasuring.com.
 
About Nova: Nova Measuring Instruments delivers continuous innovation by providing advanced metrology solutions for the semiconductor manufacturing industry. Deployed with the world’s largest integrated-circuit manufacturers, Nova’s products deliver state-of-the-art, high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova’s product portfolio, which combines high-precision hardware and cutting-edge software, supports the development and production of the most advanced devices in today’s high-end semiconductor market. Nova’s technical innovation and market leadership enable customers to improve process performance, enhance products’ yields and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices around the world. Additional information may be found at www.novameasuring.com.
 
Nova is traded on the NASDAQ & TASE under the symbol NVMI.
 

 
This press release provides financial measures that exclude charges for amortization of acquired intangible assets, net adjustment of deferred tax assets, stock-based compensation expenses, acquisition related expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding Nova's performance because they reflect our operational results and enhances management's and investors' ability to evaluate Nova's performance before charges or benefits considered by management to be outside Nova's ongoing operating results. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management believes that it is in the best interest of its investors to provide financial information that will facilitate comparison of both historical and future results and allows greater transparency to supplemental information used by management in its financial and operational decision making. A reconciliation of each GAAP to non-GAAP financial measure discussed in this press release is contained in the accompanying financial tables.

This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but are not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in those forward looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: our dependency on three product lines; our dependency on a small number of large customers and small number of suppliers; the highly cyclical and competitive nature of the markets we target and we operate in; our inability to reduce spending during a slowdown in the semiconductor industry; our ability to respond effectively on a timely basis to rapid technological changes; our ability to recognize the benefits of ReVera acquisition and risks that the acquisition may disrupt current plans and operations and impact relationships with customers, distributors and suppliers; our dependency on PEMs; risks related to exclusivity obligations and non-limited liability that may be included in our commercial agreements and arrangements; our ability to retain our competitive position despite the ongoing consolidation in our industry; risks related to our dependence on our manufacturing facilities; risks related to changes in our order backlog; risks related to the worldwide financial instabilities; risks related to our intellectual property; new product offerings from our competitors; unanticipated manufacturing or supply problems; risks related to government programs we participate in; risks related to taxation; changes in customer demand for our products; risks related to currency fluctuations, risks related to acquisitions we may pursue and risks related to our operations in Israel. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading “Risk Factors” in Nova’s Annual Report on Form 20-F for the year ended December 31, 2015 filed with the Securities and Exchange Commission on February 29, 2016. These factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Measuring Instruments Ltd. does not assume any obligation to update the forward-looking information contained in this press release.

(Tables to Follow)
 


NOVA MEASURING INSTRUMENTS LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands) - (Unaudited)
 
   
As of
 
 
 
ASSETS
 
September 30,
2016
   
December 31,
2015
(Audited)
 
Current assets
           
Cash and cash equivalents
   
23,654
     
27,733
 
Short-term interest-bearing bank deposits
   
69,548
     
69,298
 
Trade accounts receivable
   
23,558
     
19,046
 
Inventories
   
28,889
     
27,683
 
Deferred tax assets
   
4,773
     
3,540
 
Other current assets
   
3,472
     
2,888
 
                 
Total current assets
   
153,894
     
150,188
 
                 
Long-term assets
               
Long-term interest-bearing bank deposits
   
750
     
750
 
Deferred tax assets
   
5,284
     
5,735
 
Severance pay funds
   
1,485
     
1,514
 
Property and equipment, net
   
9,266
     
11,062
 
Identifiable intangible assets, net
   
15,997
     
17,906
 
Goodwill
   
20,114
     
20,114
 
                 
Total long-term assets
   
52,896
     
57,081
 
                 
Total assets
   
206,790
     
207,269
 
                 
 LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities
               
Trade accounts payable
   
12,374
     
14,378
 
Deferred revenues
   
4,423
     
5,828
 
Deferred tax liabilities
   
1,064
     
956
 
Other current liabilities
   
15,352
     
15,996
 
                 
Total current liabilities
   
33,213
     
37,158
 
                 
Long-term liabilities
               
Deferred tax liabilities
   
5,039
     
5,760
 
Liability for employee severance pay
   
2,535
     
2,469
 
Other long-term liabilities
   
921
     
822
 
                 
Total long-term liabilities
   
8,495
     
9,051
 
                 
Shareholders' equity
   
165,082
     
161,060
 
                 
Total liabilities and shareholders’ equity
   
206,790
     
207,269
 
 

 
NOVA MEASURING INSTRUMENTS LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 (U.S. dollars in thousands, except per share data) - (Unaudited)

   
Three months ended
   
Nine months ended
 
   
September 30,
2016
   
September 30,
2015
   
September 30,
2016
   
September 30,
2015
 
                         
Revenues:
                       
Products
   
32,944
     
30,412
     
82,633
     
80,597
 
Services
   
11,116
     
10,034
     
31,058
     
27,895
 
Total revenues
   
44,060
     
40,446
     
113,691
     
108,492
 
                                 
Cost of revenues:
                               
Products
   
13,127
     
12,610
     
33,080
     
34,592
 
Services
   
6,476
     
5,189
     
18,725
     
15,219
 
Expense related to royalty buyout agreement with the Office of the Chief Scientist
   
12,875
     
-
     
12,875
     
-
 
Inventory write-off
   
1,889
     
-
     
1,889
     
-
 
Amortization of acquired intangible assets in cost of products
   
-
     
13
     
-
     
2,455
 
Total cost of revenues
   
34,367
     
17,812
     
66,569
     
52,266
 
                                 
Gross profit
   
9,693
     
22,634
     
47,122
     
56,226
 
                                 
Operating expenses:
                               
Research and development expenses, net
   
9,181
     
10,974
     
25,773
     
28,877
 
Sales and marketing expenses
   
5,020
     
4,228
     
14,922
     
11,294
 
General and administration expenses
   
1,802
     
1,613
     
5,133
     
4,250
 
Acquisition related expenses
   
-
     
-
     
-
     
2,655
 
Amortization of acquired intangible assets
   
637
     
570
     
1,909
     
1,139
 
Total operating expenses
   
16,640
     
17,385
     
47,737
     
48,215
 
                                 
Operating income (loss)
   
(6,947
)
   
5,249
     
(615
)
   
8,011
 
                                 
Financing income, net
   
301
     
94
     
1,026
     
459
 
                                 
Income (loss) before tax on income
   
(6,646
)
   
5,343
     
411
     
8,470
 
                                 
Income tax expenses (benefit)
   
(1,868
)
   
(94
)
   
(869
)
   
(2,094
)
                                 
Net income (loss) for the period
   
(4,778
)
   
5,437
     
1,280
     
10,564
 
                                 
Earnings (loss) per share:
                               
Basic
   
(0.18
)
   
0.20
     
0.05
     
0.39
 
Diluted
   
(0.18
)
   
0.20
     
0.05
     
0.38
 
                                 
Shares used for calculation of earnings (loss) per share:
                               
                                 
Basic
   
27,169
     
27,172
     
27,136
     
27,224
 
Diluted
   
27,169
     
27,481
     
27,361
     
27,507
 


NOVA MEASURING INSTRUMENTS LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S. dollars in thousands) - (Unaudited)

   
Three months ended
   
Nine months ended 
 
   
September 30, 2016
   
September 30, 2015
   
September 30, 2016
   
September 30, 2015
 
Cash flows from operating activities:
                       
Net income (loss) for the period
   
(4,778
)
   
5,437
     
1,280
     
10,564
 
Adjustments to reconcile net income to net cash
provided by (used in) operating activities:
                               
Depreciation
   
1,191
     
1,103
     
3,540
     
3,309
 
Amortization of acquired intangible assets
   
637
     
583
     
1,909
     
3,594
 
Amortization of deferred stock-based compensation
   
639
     
778
     
2,044
     
1,908
 
Increase (decrease) in liability for employee termination benefits, net
   
(1
)
   
(49
)
   
95
     
35
 
Deferred tax assets, net
   
(1,813
)
   
(482
)
   
(1,395
)
   
(2,969
)
Loss on securities
   
-
     
81
     
-
     
13
 
Increase in trade accounts receivable
   
(783
)
   
(1,873
)
   
(4,512
)
   
(6,256
)
Decrease (increase) in inventories
   
1,722
     
(1,431
)
   
(1,335
)
   
(2,694
)
Increase in other current and long term assets
   
(687
)
   
(459
)
   
(295
)
   
(502
)
Increase (decrease) in trade accounts payable
   
(760
)
   
(2,428
)
   
(2,004
)
   
135
 
Increase (decrease) in other current and other long-term liabilities
   
2,043
     
1,964
     
(564
)
   
2,646
 
Increase (decrease) in short and long term deferred revenues
   
701
     
4,132
     
(1,405
)
   
3,289
 
                                 
Net cash provided by (used in) operating activities
   
(1,889
)
   
7,356
     
(2,642
)
   
13,072
 
                                 
Cash flow from investment activities:
                               
Decrease (increase) in short-term interest-bearing bank deposits
   
5,682
     
(450
)
   
(250
)
   
48,036
 
Acquisition of subsidiary, net of acquired cash
   
-
     
-
     
-
     
(45,344
)
Additions to property and equipment
   
(535
)
   
(644
)
   
(1,615
)
   
(2,168
)
                                 
Net cash provided by (used in) investment activities
   
5,147
     
(1,094
)
   
(1,865
)
   
524
 
                                 
Cash flows from financing activities:
                               
Purchases of treasury shares
   
-
     
(2,913
)
   
(937
)
   
(4,302
)
Shares issued under employee stock-based plans
   
941
     
138
     
1,365
     
2,087
 
                                 
Net cash provided by (used in) financing activities
   
941
     
(2,775
)
   
428
     
(2,215
)
                                 
Increase (decrease) in cash and cash equivalents
   
4,199
     
3,487
     
(4,079
)
   
11,381
 
Cash and cash equivalents – beginning of period
   
19,455
     
21,543
     
27,733
     
13,649
 
Cash and cash equivalents – end of period
   
23,654
     
25,030
     
23,654
     
25,030
 


NOVA MEASURING INSTRUMENTS LTD.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(U.S. dollars in thousands, except percentage and per share data) - (Unaudited)
 
   
Three months ended
 
   
September 30,
2016
   
June 30,
2016
   
September 30,
2015
 
GAAP cost of revenues
   
34,367
     
16,676
     
17,812
 
  Amortization of acquired intangible assets in cost of products
   
-
     
-
     
(13
)
  Expense related to royalty buyout agreement with the Office of the Chief Scientist
   
(12,875
)
   
-
     
-
 
  Inventory write-off
   
(1,889
)
   
-
     
-
 
  Stock-based compensation in cost of products
   
(79
)
   
(79
)
   
(109
)
  Stock-based compensation in cost of services
   
(52
)
   
(48
)
   
(62
)
Non-GAAP cost of revenues
   
19,472
     
16,549
     
17,628
 
                         
GAAP gross profit
   
9,693
     
18,899
     
22,634
 
Gross profit adjustments
   
14,895
     
127
     
184
 
Non-GAAP gross profit
   
24,588
     
19,026
     
22,818
 
GAAP gross margin as a percentage of revenues
   
22
%
   
53
%
   
56
%
Non-GAAP gross margin as a percentage of revenues
   
56
%
   
53
%
   
56
%
                         
GAAP operating expenses
   
16,640
     
15,376
     
17,385
 
  Stock-based compensation in research and development
   
(200
)
   
(230
)
   
(318
)
  Stock-based compensation in sales and marketing
   
(226
)
   
(237
)
   
(205
)
  Stock-based compensation in general and administrative
   
(82
)
   
(55
)
   
(84
)
  Amortization of acquired intangible assets
   
(637
)
   
(636
)
   
(570
)
Non-GAAP operating expenses
   
15,495
     
14,218
     
16,208
 
Non-GAAP operating income
   
9,093
     
4,808
     
6,610
 
GAAP operating margin as a percentage of revenues
   
(16
)%
   
10
%
   
13
%
Non-GAAP operating margin as a percentage of revenues
   
21
%
   
14
%
   
16
%
                         
GAAP tax on income
   
(1,868
)
   
626
     
(94
)
  Deferred tax assets adjustments, net
   
1,813
     
(265
)
   
482
 
Non-GAAP tax on income
   
(55
)
   
361
     
388
 
                         
GAAP net income (loss)
   
(4,778
)
   
3,153
     
5,437
 
  Amortization of acquired intangible assets
   
637
     
636
     
583
 
  Expense related to royalty buyout agreement with the Office of the Chief Scientist
   
12,875
     
-
     
-
 
  Stock-based compensation expenses
   
639
     
649
     
778
 
  Deferred tax assets adjustments, net
   
(1,813
)
   
265
     
(482
)
  Inventory write-off
   
1,889
     
-
     
-
 
Non-GAAP net income
   
9,449
     
4,703
     
6,316
 
                         
GAAP basic earnings (loss) per share
   
(0.18
)
   
0.12
     
0.20
 
Non-GAAP basic earnings per share
   
0.35
     
0.17
     
0.23
 
                         
GAAP diluted earnings (loss) per share
   
(0.18
)
   
0.11
     
0.20
 
Non-GAAP diluted earnings per share
   
0.34
     
0.17
     
0.23
 
                         
Shares used for calculation of earnings (loss) per share:
                       
  Basic
   
27,169
     
27,123
     
27,172
 
  Diluted
   
27,536
     
27,422
     
27,481